Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
3 clinical trials · Condition
◉ Watch Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
| Record | Firm | Date |
|---|---|---|
| Observational Prospective Study OPTIMA II - Follow-up (NCT02099565) | AstraZeneca | 2014-05-01 |
Track Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) automatically
Every clearance here is in the API, with alerts when new ones post.